CDK4 and neoplasm: Combined treatment with the CDK4/6 inhibitor further blocks escaping cells in the G1/S checkpoint, leading to enhanced cell cycle arrest and tumor regression.479 Clinical trials for combination of G12C inhibitors and CDK4/6 inhibitors are in progress (NCT04185883; NCT04165031).